MedPath

The role of umbilical cord serum therapy on corneal epithelial defect

Phase 2
Conditions
corneal epithelial defect.
Disorder of cornea, unspecified
Registration Number
IRCT138903241180N15
Lead Sponsor
Ophthalmic Research Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Diabetic patients with corneal epithelial defect following diabetic vitrectomy at labbafinejad hospital. Exclusion criteria: 1) Any history of Eye herpes infection, Refractive surgery, Autoimmune disease, Immune defficiency; 2) patients with one eye 3) use of any eye drops except Chloramphenicol, Betamethasone, Cycloplegic and contact lens for corneal epithelial defect.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measurement of corneal epithelial defect. Timepoint: days 3,5,7,12. Method of measurement: slit lamp.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath